Lemoine et al. [21] identified biallelic missense mutations in tetratricopeptide repeat domain 7 A (TTC7A) that inappropriately activated RhoA signaling in IBD patients with an immune deficiency. The gene discussed is RHOA; the disease is inflammatory bowel disease.